Sunday, September 7, 2014

Speaking of Marijuana

Here are three photos of marijuana products manufactured in the US prior to the rescheduling of the product by the DEA. You'll notice that two have poison on the bottle, and one does not. Perhaps the product should be regulated the same way as Psuedophedrine, behind the counter? Perhaps the US should have products which require patients to speak to a pharmacy worker first? Do our Australian cousins have it right (which have 3 types of medicines: RX, OTC, and behind the counter)? I have no knowledge of what schedule Australia considers marijuana. Image source: wikimedia commons.

https://commons.wikimedia.org/wiki/Cannabis_sativa#/media/File:Lilly96B.jpg

https://commons.wikimedia.org/wiki/Cannabis_sativa#/media/File:Lilly96A.jpg




No comments: